INTEGRA LIFESCIENCES HOLDINGS CORP (IART) Debt Components
- 2026-06-30: Secured Debt, CurrentUSD $43.59M; Long-term DebtUSD $707.19M; Long-Term Debt, Maturity, Year OneUSD $53.28M; Long-Term Debt, Maturity, Year TwoUSD $634.53M.
- 2026-03-31: Secured Debt, CurrentUSD $38.75M; Long-term DebtUSD $716.88M; Long-Term Debt, Maturity, Year OneUSD $53.28M; Long-Term Debt, Maturity, Year TwoUSD $634.53M.
- 2025-12-31: Secured Debt, CurrentUSD $38.75M; Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m); Long-Term Debt, Maturity, Year TwoUSD (m).
- 2025-12-31: Secured Debt, CurrentUSD (m); Long-term DebtUSD $726.56M; Long-Term Debt, Maturity, Year OneUSD $38.75M; Long-Term Debt, Maturity, Year TwoUSD $53.28M.
INTEGRA LIFESCIENCES HOLDINGS CORP Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Secured Debt, Current USD | Long-term Debt USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Remainder of Fiscal Year USD | Long-Term Debt, Maturity, Year Four USD | Long-Term Debt, Maturity, Year Five USD | Long-Term Debt, Maturity, after Year Five USD | Line of Credit Facility, Maximum Borrowing Capacity USD | Line of Credit Facility, Remaining Borrowing Capacity USD | Debt Instrument, Fair Value Disclosure USD | Debt Instrument, Interest Rate, Stated Percentage pure | Long-term Debt, Maturities, Repayments of Principal in Next Rolling Twelve Months USD | Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $43.59M | $707.19M | $53.28M | $634.53M | (m) | $19.38M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $38.75M | $716.88M | $53.28M | $634.53M | (m) | $29.06M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $38.75M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $726.56M | $38.75M | $53.28M | $634.53M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $38.75M | $736.25M | $38.75M | $53.28M | $634.53M | $9.69M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $38.75M | $745.94M | $38.75M | $53.28M | $634.53M | $19.38M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $38.75M | $755.62M | $38.75M | $53.28M | $634.53M | $29.06M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $33.91M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | $760.47M | $33.91M | $38.75M | $53.28M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $29.06M | $765.31M | $33.91M | $38.75M | $53.28M | $4.84M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $24.22M | $770.16M | $33.91M | $38.75M | $53.28M | $9.69M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $19.38M | $775.00M | $33.91M | $38.75M | $53.28M | $14.53M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $14.53M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $775.00M | $14.53M | $33.91M | $38.75M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $9.69M | $775.00M | $14.53M | $33.91M | $38.75M | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $4.84M | $775.00M | $14.53M | $33.91M | $38.75M | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $0.00 | $775.00M | $14.53M | $33.91M | $38.75M | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $38.12M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $775.00M | $38.12M | $67.50M | $669.38M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | $56.25M | $810.00M | $61.88M | $67.50M | $669.38M | $11.25M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $50.62M | $821.25M | $61.88M | $67.50M | $669.38M | $22.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $45.00M | $832.50M | $61.88M | $67.50M | $669.38M | $33.75M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $45.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $843.75M | $45.00M | $61.88M | $67.50M | (m) | $669.38M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | $45.00M | $855.00M | $45.00M | $61.88M | $67.50M | $11.25M | $669.38M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | $45.00M | $866.25M | $45.00M | $61.88M | $67.50M | $22.50M | $669.38M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | $45.00M | $877.50M | $45.00M | $61.88M | $67.50M | $33.75M | $669.38M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $33.75M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $877.50M | $33.75M | $45.00M | $61.88M | (m) | $67.50M | $669.38M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | $22.50M | $877.50M | $33.75M | $45.00M | $61.88M | $0.00 | $67.50M | $669.38M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | $11.25M | $877.50M | $33.75M | $45.00M | $61.88M | $0.00 | $67.50M | $669.38M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | $0.00 | $877.50M | (m) | $33.75M | $45.00M | $0.00 | $61.88M | $67.50M | $669.38M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $45.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $877.50M | $45.00M | $56.25M | $67.50M | (m) | $708.75M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | $45.00M | $888.75M | (m) | $45.00M | $56.25M | $11.25M | $67.50M | $708.75M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | $45.00M | $900.00M | (m) | $45.00M | $56.25M | $22.50M | $67.50M | $708.75M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | $33.75M | $900.00M | (m) | $45.00M | $56.25M | $22.50M | $67.50M | $708.75M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $22.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | $900.00M | $22.50M | $45.00M | $56.25M | (m) | $67.50M | $708.75M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | $11.25M | $900.00M | (m) | $22.50M | $45.00M | $0.00 | $56.25M | $67.50M | $708.75M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | $0.00 | $900.00M | (m) | $22.50M | $45.00M | $0.00 | $56.25M | $67.50M | $708.75M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-05-03 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.20B | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | $60.00M | $1.19B | (m) | $60.00M | $90.00M | $45.00M | $990.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $60.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | (m) | (m) | $60.00M | $90.00M | (m) | $990.00M | (m) | (m) | (m) | (m) | (m) | (m) | $60.00M | (m) |
| 2017-09-30 | $18.75M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | $12.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.20B | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | $6.25M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.50B | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-09-30 | $28.75M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | $21.25M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | $17.81M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | $14.38M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | $10.94M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | $7.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | $5.62M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | $3.75M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | $1.88M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $278.10M | $306.70M | (m) | (m) | $321.90M |
| 2011-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $179.70M |
| 2011-03-31 | $69.38M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $108.44M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-09-30 | $7.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2007-06-11 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 2.38% | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |